CoChat
Sign Up
Cited by 116Liver Disease Diagnosis and TreatmentPhytochemicals and Antioxidant ActivitiesNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease

Open access
Zhang, Pei-Wen, Chen, Feng-Xia, Li, Di, Ling, Wen-Hua, Guo, Hong-Hui·2015·Medicine
DOI 10.1097/md.0000000000000758PMC PMC4602870
Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease that can progress to cirrhosis and liver failure. Anthocyanin, a member of the flavonoid family, has been shown to ameliorate NAFLD-associated pathologies in rodents.The aim of this CONSORT-compliant pilot study is to evaluate the effects of anthocyanin supplementation on insulin resistance and liver injury biomarkers in patients with NAFLD.A total of 74 subjects with NAFLD were divided into 2 groups in this double-blind, randomized study. Patients received either purified anthocyanin (320 mg/d) derived from bilberry and black currant or placebo for 12 weeks. Diet, physical activity, anthropometric parameters, glucose tolerance, and a set of biomarkers related to NAFLD were evaluated before and after intervention.No significant differences were observed in nutrient intake, physical activity, anthropometric parameters, or plasma lipid profile between patients receiving anthocyanin or placebo. Compared to controls, the anthocyanin group exhibited significant decreases (P < 0.05, all comparisons) in plasma alanine aminotransferase (-19.1% vs 3.1%), cytokeratin-18 M30 fragment (-8.8% vs 5.6%) and myeloperoxidase (-75.0% vs -44.8%). Significant decreases from baseline in fasting blood glucose and homeostasis model assessment for insulin resistance were observed in the anthocyanin group; however, these differences were not significant relative to placebo controls. In addition, the oral glucose tolerance test indicated that anthocyanin supplementation significantly decreased the 2-hour loading glucose level compared to control (-18.7% vs -3.8%, P = 0.02).A 12-week supplement of purified anthocyanin improved insulin resistance, indicators of liver injury, and clinical evolution in NAFLD patients. Further studies are warranted to determine the clinical applications of anthocyanin in NAFLD.This trial was registered at clinicaltrials.gov as NCT01940263.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000000758

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Consolidated standards of reporting trials flow diagram of the study participants.
FIGURE 1 Consolidated standards of reporting trials flow diagram of the study participants.CC BY-NC · PubMed Central
FIGURE 2 Effect of the 12-week anthocyanin intervention on ALT levels in NAFLD patients. The columns and error bars indicate medians with quartiles. After intervention, no differences were observed between the 2 groups across intragender comparisons; however, the total mean reduction of ALT levels in the anthocyanin group was greater than that in the placebo group (a), P compared difference between 2 groups by Mann–Whitney U test. Compared with baseline, there is a remarkable decline in ALT after a 12-week intervention in males, females, and total patients in the anthocyanin group (b, c), but only in females in the placebo group (b, d). P compared with the basal values in each group by Wilcoxon matched pairs signed rank test.
FIGURE 2 Effect of the 12-week anthocyanin intervention on ALT levels in NAFLD patients. The columns and error bars indicate medians with quartiles. After intervention, no differences were observed between the 2 groups across intragender comparisons; however, the total mean reduction of ALT levels in the anthocyanin group was greater than that in the placebo group (a), P compared difference between 2 groups by Mann–Whitney U test. Compared with baseline, there is a remarkable decline in ALT after a 12-week intervention in males, females, and total patients in the anthocyanin group (b, c), but only in females in the placebo group (b, d). P compared with the basal values in each group by Wilcoxon matched pairs signed rank test.CC BY-NC · PubMed Central
FIGURE 3 Changes in glucose concentration measured 2 h after a 75-g oral glucose load in the 2 treatments during the study period. P compared difference between 2 groups by independent-sample t test.
FIGURE 3 Changes in glucose concentration measured 2 h after a 75-g oral glucose load in the 2 treatments during the study period. P compared difference between 2 groups by independent-sample t test.CC BY-NC · PubMed Central
FIGURE 4 Correlation between changes in plasma ALT activities and the levels of CK-18 M30; n = 37 in each group. The data were evaluated by using Pearson correlation coefficients (r).
FIGURE 4 Correlation between changes in plasma ALT activities and the levels of CK-18 M30; n = 37 in each group. The data were evaluated by using Pearson correlation coefficients (r).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 116

Related

See all

Metadata

Authors
Zhang, P.-W., Chen, F.-X., Li, D., Ling, W.-H., & Guo, H.-H.
Affiliations
Sun Yat-sen University (CN)
ORCID
Li, Di
Venue
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2015-05
Volume
94
Issue
20
Pages
e758
ISSN
0025-7974 (ISSN-L)
DOI
10.1097/md.0000000000000758
PMC
PMC4602870
OpenAlex
W2301998872
Cited by
116
References
40
Citations by year
2026: 5 · 2025: 9 · 2024: 11 · 2023: 18 · 2022: 7 · 2021: 20 · 2020: 12 · 2019: 10 · 2018: 11 · 2017: 8 · 2016: 2 · 2015: 3
FWCI
6.28
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Medicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
National Key Research and Development Program of China (2012CB517506)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
non-alcoholic fatty liver disease, anthocyanins, Vaccinium myrtillus, black currant, flavonoids, dietary supplementation, insulin resistance, liver injury biomarkers, alanine aminotransferase, myeloperoxidase, oral glucose tolerance, fasting blood glucose
MeSH terms
Adult, Anthocyanins, Cholesterol, Double-Blind Method, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Lipoproteins, LDL, Male, Middle Aged, Pilot Projects, Triglycerides, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review